Abstract
Estrogen receptors have been found in normal and neoplastic gastrointestinal mucosa. The aim of our study was to verify whether the content of cytosolic estrogen receptor in normal and neoplastic tissue has a prognostic value in patients with colorectal adenocarcinoma. Eighty consecutive patients entered the study, and their follow-up was complete because non were lost to follow-up. Estrogen receptors were evaluated by an enzymatic immunoassay. Fifty-four percent of neoplastic samples and 84% of samples from surrounding mucosa showed an estrogen receptor content higher than 1.0 fmol/mg of cytosolic proteins (cut point for positive/negative hormone receptor status). Estrogen receptor levels were lower in neoplastic tissue than surrounding mucosa (1.2±1.05 fmol/mg protein vs 2.07±1.36 fmol/mg protein, respectively,t testP=0.001). The survival of patients with estrogen receptor expression in uninvolved surrounding mucosa was longer than that of patients without estrogen receptor in the same type of mucosa (log rank test,P<0.01). In the neoplastic tissue, receptor status had no prognostic value (log rank,P=0.8). After taking into account the most important potential confounders by using the Cox proportional hazard model, the estrogen receptor status in normal mucosa samples maintained an independent prognostic value. These results support an association between the estrogen receptor status in normal mucosa and survival of patients with colorectal adenocarcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Utsumi Y, Nakamura T, Nagasue N, Kubota H, Morikawa S: Role of estrogen receptors in the growth of human esophageal carcinoma. Cancer 64:88–93, 1989
Tokunaka A, Nishi K, Matsukura R, Tanaka N, Onda M, Shirota A, Asano G, Hayashi K: Estrogen and progesterone receptors in gastric cancer. Cancer 57:1376–1379, 1986
Yamamoto N, Nakajo S, Tahara E: Immunohistochemical analysis of estrogen receptors in human gallbladder. Acta Pathol Jpn 40:14–21, 1990
Greenway B, Iqbal MJ, Johnson PJ, Williams R: Oestrogen receptor protein in malignant fetal pancreas. Br Med J 283:751–753, 1989
McClendon JE, Appleby D, Claudon DB, Donegan WL, De Cosse JJ: Colonic neoplasms, tissue estrogen receptor and carcinoembryonic antigen. Arch Surg 112:140–141, 1977
Alford TC, Do HM, Geelhead GW: Steroid hormone receptor in human colon cancer. Cancer 43:980–984, 1979
Sica V, Nola E, Contieri E: Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 44:4670–4674, 1984
Wobbes T, Beex LV, Koenders AM: Estrogen and progestinic receptors in colonic cancer. Dis Colon Rectum 27:51–52, 1984
Francavilla A, Di Leo A, Polimeno L, Conte D, Barone M, Fanizza G, Chiumarulo C, Rizzo G, Rubino M: Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 93:1301–1306, 1987
Takeda H, Yamakawa M, Takahashi T, Imai Y, Ishikawa M: An immunohistochemical study with an estrogen receptor-related protein (ER-D5) in human colorectal cancer. Cancer 69:907–912, 1992
Di Leo A, Linsalata M, Cavallini A, Messa C, Russo F: Sex steroid hormone receptors, epidermal growth factor receptor and polyamines in human colorectal cancer. Dis Colon Rectum 35:305–309, 1992
Russo F, Linsalata M, Messa C, Cavallini A, Notarnicola M, Guerra V, Lantone G, Lacatena M, Di Leo A: Polyamines and estrogen receptor concentrations in human colorectal carcinomas. Ital J Gastroenterol 24:8–12, 1992
Mc Guire WL, Carbone PP, Vollner EP: Estrogen Receptors in Human Breast Cancer. New York, Raven Press, 1975, pp 37–56
Soutter WP, Leake RE: Steroid hormone receptors in gynaecological cancers.In Recent Advances in Obstetrics and Gynaecology, Vol. 15. J Bonner (ed). Edinburgh, Churchill Livingstone, 1987, pp 175–194
Lowry OH, Rosebrough NJ, Farr AL, Randall RS: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267, 1951
Coffer AI, Lewis KM, Bockas AJ: Monoclonal antibodies against a component related to soluble antigen receptor. Cancer Res 45:3686–3693, 1985
Christensen E: Multivariate survival analysis using Cox's regression model. Hepatology 7:1346–1358, 1987
Dora J, Andre J, Gautier R, Burtin P: Abnormal pattern of mucus-associated M1 antigens in histologically normal mucosa adjacent to colonic adenocarcinomas. Cancer Res 44:4040–4045, 1984
Tayler R, Cumberland VH, Piper DW: Lactate dehydrogenase isoenzyme pattern in uninvolved mucosa of patients with colorectal carcinoma. Gut 18:45–47, 1977
Filipe MI, Branfoot AC: Abnormal pattern of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer 34:282–290, 1974
Langvad E: Lactate dehydrogenase isoenzyme pattern in the tumor bearing colon. Int J Cancer 3:17–29, 1968
La Muraglia GM, Lacaine F, Malt RA: High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia. Ann Surg 204:89–93, 1986
Coffey RJ, Shipley GD, Moses HL: Production of transforming growth factors by human colon cancer lines. Cancer Res 46:1164–1169, 1986
Goustin AS, Leof EB, Shipley GD, Moses HL: Growth factors and cancer. Cancer Res 46:1015–1029, 1986
Sporn MB, Roberts AB: Introduction: autocrine, paracrine, and endocrine mechanism and growth control. Cancer Surv 4:627–632, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Di Leo, A., Messa, C., Russo, F. et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Digest Dis Sci 39, 2038–2042 (1994). https://doi.org/10.1007/BF02088144
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02088144